| |
| |
|
| Insider
Information: |
Patterson Leone D |
| Relationship: |
|
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
197,871 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$961,402 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
197,871 |
|
|
| Total
Value |
$961,402 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -159.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Paratek Pharmaceuticals Inc |
PRTK |
Vice President, CFO |
2014-10-30 |
4,161 |
2014-10-30 |
0 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
President and CFO |
2021-02-09 |
97,955 |
2016-06-15 |
0 |
Premium* |
|
|
Tenaya Therapeutics, Inc. |
TNYA |
|
2024-02-23 |
95,755 |
2023-02-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNYA |
Tenaya Therapeutics, Inc. |
Chief Fin. and Bus. Officer |
• – – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
95,755 |
0 |
- |
|
| TNYA |
Tenaya Therapeutics, Inc. |
Chief Fin. and Bus. Officer |
• – – |
2024-02-16 |
4 |
S |
$5.86 |
$30,478 |
D/D |
(5,201) |
60,755 |
0 |
- |
|
| TNYA |
Tenaya Therapeutics, Inc. |
Chief Fin. and Bus. Officer |
• – – |
2023-08-16 |
4 |
S |
$3.81 |
$16,962 |
D/D |
(4,452) |
64,542 |
0 |
- |
|
| TNYA |
Tenaya Therapeutics, Inc. |
Chief Fin. and Bus. Officer |
• – – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
67,000 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
President and CFO |
• – – |
2021-02-09 |
4 |
S |
$14.10 |
$176,718 |
D/D |
(12,533) |
97,955 |
0 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
President |
• – – |
2020-06-16 |
4 |
S |
$24.68 |
$325,060 |
D/D |
(13,171) |
110,488 |
0 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2020-05-06 |
4 |
OE |
$3.44 |
$68,800 |
D/D |
20,000 |
143,659 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2020-05-06 |
4 |
AS |
$20.02 |
$400,400 |
D/D |
(20,000) |
123,659 |
0 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2020-03-20 |
4 |
AS |
$10.17 |
$401,908 |
D/D |
(39,526) |
123,429 |
0 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2020-03-20 |
4 |
OE |
$3.44 |
$84,019 |
D/D |
24,424 |
162,955 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2020-03-17 |
4 |
AS |
$10.02 |
$4,749 |
D/D |
(474) |
138,531 |
0 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2020-02-09 |
4/A |
D |
$10.24 |
$112,486 |
D/D |
(10,985) |
139,235 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2020-02-09 |
4 |
D |
$10.24 |
$114,842 |
D/D |
(11,215) |
139,005 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2019-12-23 |
4/A |
AS |
$10.72 |
$428,800 |
D/D |
(40,000) |
150,220 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2019-12-23 |
4 |
AS |
$10.72 |
$428,800 |
D/D |
(40,000) |
228,496 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2019-06-15 |
4 |
D |
$10.82 |
$474,479 |
D/D |
(43,852) |
190,220 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2019-02-09 |
4 |
D |
$3.33 |
$27,226 |
D/D |
(8,176) |
234,072 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2018-06-15 |
4 |
D |
$5.55 |
$47,980 |
D/D |
(8,645) |
242,248 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, CFO, Interim Pres and CEO |
• – – |
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
268,496 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2018-02-09 |
4 |
D |
$7.05 |
$57,866 |
D/D |
(8,208) |
162,397 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2017-06-15 |
4 |
D |
$2.70 |
$25,367 |
D/D |
(9,395) |
170,605 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CFO |
• – – |
2017-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
180,000 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CFO |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Vice President, CFO |
• – – |
2014-10-30 |
4 |
A |
$21.59 |
$89,828 |
D/D |
4,161 |
4,161 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
